Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
MAIA Biotechnology, Inc. (($MAIA)) announced an update on their ongoing clinical study. MAIA Biotechnology, Inc. is conducting a Phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback